Details for New Drug Application (NDA): 061889
✉ Email this page to a colleague
The generic ingredient in TETREX is tetracycline phosphate complex. There are ninety-nine drug master file entries for this compound. Additional details are available on the tetracycline phosphate complex profile page.
Summary for 061889
Tradename: | TETREX |
Applicant: | Bristol |
Ingredient: | tetracycline phosphate complex |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG HYDROCHLORIDE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG HYDROCHLORIDE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription